Catalyst Pharmaceuticals Inc
CPRX
Market Cap$2.85B
Close$
$16.80
29% downside
Current Fair Value
29% downsideOvervalued by 29% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.85 Billion |
|---|---|
| Enterprise Value | $2.34 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $1.38 |
| Beta | 0.7 |
| Outstanding Shares | 119,892,062 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 17.1 |
|---|---|
| PEG | -7.05 |
| Price to Sales | 7.88 |
| Price to Book Ratio | 3.94 |
| Enterprise Value to Revenue | 5.1 |
| Enterprise Value to EBIT | 13.43 |
| Enterprise Value to Net Income | 16 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Catalyst Pharmaceuticals Inc
CEO: Patrick McEnany